E-LIB Suche - Ergebnisse für: Arnold, Douglas L

1

Efficacy and safety results after >3.5 years of treatment w..:

Montalban, Xavier ; Piasecka-Stryczynska, Karolina ; Kuhle, Jens...
Multiple Sclerosis Journal. 30 (2024) 4-5 - p. 558-570 , 2024

Link: https://doi.org/10.1177/..

2

Teriflunomide in pediatric patients with relapsing multiple..:

Chitnis, Tanuja ; Banwell, Brenda ; Kappos, Ludwig...
Multiple Sclerosis Journal. 30 (2024) 7 - p. 833-842 , 2024

Link: https://doi.org/10.1177/..

3

Epstein–Barr Virus Strongly Associates With Pediatric Multi..:

Fadda, Giulia ; Yea, Carmen ; O'Mahony, Julia...
Annals of Neurology. 95 (2024) 4 - p. 700-705 , 2024

Link: https://doi.org/10.1002/..

4

Sécurité et efficacité clinique du Tolebrutinib dans l'étud..:

Oh, Jiwon ; Reich, Daniel S. ; Traboulsee, Anthony...
Revue Neurologique. 180 (2024) - p. S158-S159 , 2024

Link: https://doi.org/10.1016/..

5

Résultats de l'étude d'extension NOVA évaluant la préférenc..:

Wiendl, Heinz ; Foley, John ; Defer, Gilles...
Revue Neurologique. 180 (2024) - p. S145 , 2024

Link: https://doi.org/10.1016/..

6

Patient Preference for Subcutaneous Versus Intravenous Admi..:

Wiendl, Heinz ; Foley, John ; Defer, Gilles...
Neurology and Therapy. , 2024

Link: https://doi.org/10.1007/..

7

Effect of Evobrutinib on Slowly Expanding Lesion Volume in ..:

Arnold, Douglas L. ; Elliott, Colm ; Martin, Emily C....
Neurology. 102 (2024) 5 - p. , 2024

Link: https://doi.org/10.1212/..

8

Brain volume increase after discontinuing natalizumab thera..:

Nakamura, Kunio ; Elliott, Colm ; Lee, Hyunwoo..
Multiple Sclerosis and Related Disorders. 81 (2024) - p. 105123 , 2024

Link: https://doi.org/10.1016/..

9

Progressive lesional pathology in MS – what we've been miss..:

Arnold, Douglas ; Elliott, Colm
Journal of the Neurological Sciences. 455 (2023) - p. 120879 , 2023

Link: https://doi.org/10.1016/..

10

Plasma neurofilament light chain in children with relapsing..:

Kuhle, Jens ; Chitnis, Tanuja ; Banwell, Brenda...
Multiple Sclerosis Journal. , 2023

Link: https://doi.org/10.1177/..

11

Données IRM, efficacité et sécurité d'emploi du tolébrutini..:

Fox, Robert J. ; Oh, Jiwon ; Arnold, Douglas...
Revue Neurologique. 179 (2023) - p. S169-S170 , 2023

Link: https://doi.org/10.1016/..

12

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibit..:

Montalban, Xavier ; Wolinsky, Jerry S. ; Arnold, Douglas L....
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

13

Ocrelizumab-treated patients with relapsing multiple sclero..:

Kolind, Shannon ; Gaetano, Laura ; Assemlal, Haz-Edine...
Multiple Sclerosis Journal. 29 (2023) 6 - p. 741-747 , 2023

Link: https://doi.org/10.1177/..

14

Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor..:

Vermersch, Patrick ; Giovannoni, Gavin ; Wolinsky, Jerry...
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105288 , 2023

Link: https://doi.org/10.1016/..

15

MRI, Efficacy, and Safety of Tolebrutinib in Patients with ..:

Fox, Robert ; Oh, Jiwon ; Arnold, Douglas...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..